[
  {
    "headline": "Pfizer expands obesity drug portfolio with Metsera acquisition",
    "summary": null,
    "source_url": null,
    "published": null,
    "source_name": null,
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 1,
      "title": "Pfizer expands obesity drug portfolio with Metsera acquisition",
      "stories": [
        {
          "position": 1,
          "title": "Pfizer doubles down on weight-loss treatments with up to $7.3 billion Metsera buyout",
          "source": {
            "name": "Reuters",
            "icon": "https://encrypted-tbn2.gstatic.com/faviconV2?url=https://www.reuters.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
            "authors": [
              "Mariam E Sunny",
              "Michael Erman"
            ]
          },
          "link": "https://www.reuters.com/business/healthcare-pharmaceuticals/pfizer-closes-73-billion-takeover-anti-obesity-drugmaker-metsera-ft-reports-2025-09-22/",
          "thumbnail": "https://www.reuters.com/resizer/v2/PMN2KSP6HZIKBEGKPN77OEIWBU.jpg?auth=e3ce48af96019482158e38a43aa502ba7c0fe5d95ce1b8a0cedcad2810babc7d&height=2400&width=1920&quality=80&smart=true",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iJ0NnNUpiR1pMTkhRNVMzSkRjV0V4VFJEckJCanZBeWdLTWdNQnNBdw",
          "date": "09/22/2025, 01:49 PM, +0000 UTC"
        },
        {
          "position": 2,
          "title": "Pfizer seals up to $7.3bn takeover of weight loss drugmaker Metsera",
          "source": {
            "name": "Financial Times",
            "icon": "https://encrypted-tbn2.gstatic.com/faviconV2?url=https://www.ft.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
            "authors": [
              "Oliver Barnes",
              "Hannah Kuchler"
            ]
          },
          "link": "https://www.ft.com/content/aee4a71c-7ad6-4cde-852f-720a97542fac",
          "thumbnail": "https://www.ft.com/__origami/service/image/v2/images/raw/https%3A%2F%2Fd1e00ek4ebabms.cloudfront.net%2Fproduction%2F45a6ed2b-6c44-4364-85e9-9659f39ba537.jpg?source=next-article&fit=scale-down&quality=highest&width=700&dpr=1",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iL0NnNXVVVTlpYjJGMVMwUnJVMmxpVFJDS0F4aThCU2dLTWdrVkVvaEpqaXROTWdF",
          "date": "09/22/2025, 03:51 AM, +0000 UTC"
        },
        {
          "position": 3,
          "title": "Metsera (MTSR) Soars to All-Time High on $7.3-Billion Merger With Pfizer",
          "source": {
            "name": "Yahoo Finance",
            "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://finance.yahoo.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
          },
          "link": "https://finance.yahoo.com/news/metsera-mtsr-soars-time-high-181334069.html",
          "thumbnail": "https://s.yimg.com/ny/api/res/1.2/GRgw.j2mDvFaIZoNxAVyRA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD0xODAw/https://media.zenfs.com/en/insidermonkey.com/d4449f1c63e66f9eb89e0a5e8e0905d6",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNU9OemR1UzA5TmNXOWpaVlJsVFJDbUJSakVBeWdLTWdZQlVaQlBKUVk",
          "date": "09/23/2025, 06:13 PM, +0000 UTC"
        },
        {
          "position": 4,
          "title": "Pfizer to Acquire Metsera and its Next-Generation Obesity Portfolio",
          "source": {
            "name": "Business Wire",
            "icon": "https://encrypted-tbn3.gstatic.com/faviconV2?url=https://www.businesswire.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
          },
          "link": "https://www.businesswire.com/news/home/20250922965053/en/Pfizer-to-Acquire-Metsera-and-its-Next-Generation-Obesity-Portfolio",
          "thumbnail": "https://mms.businesswire.com/media/20250922965053/en/1045874/5/Pfizer_Logo_Color_RGB_APPROVED.jpg?download=1",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNUliVEl5V0dnMlduaGplSGxhVFJEd0FoakNCaWdLTWdhTmtaQXN1UVk",
          "date": "09/22/2025, 10:45 AM, +0000 UTC"
        },
        {
          "position": 5,
          "title": "Pfizer amps up push into obesity treatments with $4.9B deal for Metsera",
          "source": {
            "name": "ABC News - Breaking News, Latest News and Videos",
            "icon": "https://encrypted-tbn3.gstatic.com/faviconV2?url=https://abcnews.go.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
          },
          "link": "https://abcnews.go.com/Business/wireStory/pfizer-amps-push-obesity-treatments-49b-deal-metsera-125809920",
          "thumbnail": "https://s.abcnews.com/images/Health/wirestory_e85141f89b670b8d9a7520de3a2fd7c5_16x9_1600.jpg",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNXhhVWR0VDAxb1h6QmhSVlY0VFJDZkF4ampCU2dLTWdZaHRJaU1TUVE",
          "date": "09/24/2025, 04:43 AM, +0000 UTC"
        },
        {
          "position": 6,
          "title": "Pfizer to Buy Weight-Loss Drug Developer Metsera for Up to $7.3 Billion",
          "source": {
            "name": "The Wall Street Journal",
            "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://www.wsj.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
            "authors": [
              "Colin Kellaher"
            ]
          },
          "link": "https://www.wsj.com/health/pharma/pfizer-to-buy-weight-loss-drug-developer-metsera-for-up-to-7-3-billion-6c8ff920?gaa_at=eafs&gaa_n=ASWzDAhhHd6JbsWaarObPBW-KwfsLdYFRs1O0_zdtu90W7JZThzvbZTtv4S3&gaa_ts=68d3ffdd&gaa_sig=_TduFDgI5vb1sHE-5lH9-UYp6--RcA_xKeOjsJj9g9hVKBpqIZqKTTCY_xaPoSSojGHi78gTu3eRwkEY6q-3UQ%3D%3D",
          "thumbnail": "https://images.wsj.net/im-45699824?width=700&height=467",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNXBXbVl4TUZjeE5UQnpia001VFJERUF4aW1CU2dLTWdhNVFxQXhIUW8",
          "date": "09/22/2025, 02:54 PM, +0000 UTC"
        },
        {
          "position": 7,
          "title": "Pfizer buys back into obesity drug chase with $4.9B Metsera deal",
          "source": {
            "name": "BioPharma Dive",
            "icon": "https://encrypted-tbn2.gstatic.com/faviconV2?url=https://www.biopharmadive.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
            "authors": [
              "Jonathan Gardner"
            ]
          },
          "link": "https://www.biopharmadive.com/news/pfizer-metsera-acquire-obesity-drugs-glp1-amylin/760719/",
          "thumbnail": "https://imgproxy.divecdn.com/UpECyt78tChsHf08h2TnhckEXZLGZrKeGJgL_kbitFA/g:ce/rs:fill:1200:675:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9QZml6ZXJfUGhvdG9fMi5KUEc=.webp",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNXBMVmgwVnkxTVptbHRNRkJFVFJDZkF4ampCU2dLTWdZbG81Q05QUVk",
          "date": "09/22/2025, 03:47 PM, +0000 UTC"
        },
        {
          "position": 8,
          "title": "Pfizer to Buy Metsera for $4.9 Billion in Obesity Drug Bet",
          "source": {
            "name": "Bloomberg.com",
            "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://www.bloomberg.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
          },
          "link": "https://www.bloomberg.com/news/articles/2025-09-22/pfizer-to-buy-metsera-for-4-9-billion-in-obesity-drug-boost",
          "thumbnail": "https://assets.bwbx.io/images/users/iqjWHBFdfxIU/iv3FA.8xqXkE/v0/1200x800.jpg",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNXNOekV6TUdWR1gxVXRiRlF0VFJERUF4aW1CU2dLTWdZQmdJNld0QVk",
          "date": "09/22/2025, 01:36 PM, +0000 UTC"
        },
        {
          "position": 9,
          "title": "How Pfizer can compete in the obesity space with its Metsera acquisition (PFE:NYSE)",
          "source": {
            "name": "Seeking Alpha",
            "icon": "https://encrypted-tbn3.gstatic.com/faviconV2?url=https://seekingalpha.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL",
            "authors": [
              "Jonathan Block, MPH"
            ]
          },
          "link": "https://seekingalpha.com/news/4497181-how-pfizer-can-compete-in-obesity-space-with-its-metsera-acquisition",
          "thumbnail": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1418907713/image_1418907713.jpg?io=getty-c-w1280",
          "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNVRTWE0yTUZweVRHNDFaREpDVFJERUF4aW1CU2dLTWdhQmc1WlJzUWM",
          "date": "09/22/2025, 03:24 PM, +0000 UTC"
        }
      ],
      "topic_token": "CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2lJNHBEUER4SHlQenlFMy1tOFlDZ0FQAQ",
      "serpapi_link": "https://serpapi.com/search.json?engine=google_news&topic_token=CAAqNggKIjBDQklTSGpvSmMzUnZjbmt0TXpZd1NoRUtEd2lJNHBEUER4SHlQenlFMy1tOFlDZ0FQAQ"
    }
  },
  {
    "headline": "Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies",
    "summary": null,
    "source_url": "https://finance.yahoo.com/news/pfizer-inc-pfe-targets-4-231003971.html",
    "published": "09/23/2025, 11:10 PM, +0000 UTC",
    "source_name": "Yahoo Finance",
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 2,
      "title": "Pfizer Inc. (PFE) Targets $4.5B in Cost Savings to Fuel R&D and Innovative Therapies",
      "source": {
        "name": "Yahoo Finance",
        "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://finance.yahoo.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://finance.yahoo.com/news/pfizer-inc-pfe-targets-4-231003971.html",
      "thumbnail": "https://s.yimg.com/ny/api/res/1.2/Djg7Cg_6iy6nU_S2UH9Jmg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/2c8f851c326321f2c94ddd4776afda17",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNUZNbUpUY1ZCTk5VNDFRVVZhVFJDZkF4amtCU2dLTWdZWlVwSkpvZ2c",
      "date": "09/23/2025, 11:10 PM, +0000 UTC"
    }
  },
  {
    "headline": "Pfizer Inc is Wall Street Wrong to Give Up on This Comeback Story?",
    "summary": null,
    "source_url": "https://finance.yahoo.com/news/pfizer-inc-wall-street-wrong-091618643.html",
    "published": "09/24/2025, 09:16 AM, +0000 UTC",
    "source_name": "Yahoo Finance",
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 3,
      "title": "Pfizer Inc is Wall Street Wrong to Give Up on This Comeback Story?",
      "source": {
        "name": "Yahoo Finance",
        "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://finance.yahoo.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://finance.yahoo.com/news/pfizer-inc-wall-street-wrong-091618643.html",
      "thumbnail": "https://s.yimg.com/ny/api/res/1.2/223_omo1Pw_BwzTjrjzzhQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTM4NA--/https://media.zenfs.com/en/us.finance.gurufocus/1cb99c5128a7afe50f6d94aa68ea8886",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNDBhRTVqVUY5UVRpMUpiVEJoVFJDQUF4aUFCU2dLTWdhQkFvS0ZtZ2c",
      "date": "09/24/2025, 09:16 AM, +0000 UTC"
    }
  },
  {
    "headline": "Foster Victor Wealth Advisors LLC Has $16.48 Million Stake in Pfizer Inc. $PFE",
    "summary": null,
    "source_url": "https://www.marketbeat.com/instant-alerts/filing-foster-victor-wealth-advisors-llc-has-1648-million-stake-in-pfizer-inc-pfe-2025-09-24/",
    "published": "09/24/2025, 11:34 AM, +0000 UTC",
    "source_name": "MarketBeat",
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 4,
      "title": "Foster Victor Wealth Advisors LLC Has $16.48 Million Stake in Pfizer Inc. $PFE",
      "source": {
        "name": "MarketBeat",
        "icon": "https://encrypted-tbn3.gstatic.com/faviconV2?url=https://www.marketbeat.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://www.marketbeat.com/instant-alerts/filing-foster-victor-wealth-advisors-llc-has-1648-million-stake-in-pfizer-inc-pfe-2025-09-24/",
      "thumbnail": "https://www.marketbeat.com/logos/pfizer-inc-logo-1200x675.png?v=20221020143129",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNWZZbTFYZUU5c2VsaDNjbU5DVFJDZkF4ampCU2dLTWdhbGxKS01NUVk",
      "date": "09/24/2025, 11:34 AM, +0000 UTC"
    }
  },
  {
    "headline": "Pfizer Inc. (PFE) Proposed Acquisition of Metsera, Inc. (NYSE:PFE) 2025-09-22",
    "summary": null,
    "source_url": "https://seekingalpha.com/article/4824901-pfizer-inc-pfe-proposed-acquisition-of-metsera-inc",
    "published": "09/22/2025, 05:47 PM, +0000 UTC",
    "source_name": "Seeking Alpha",
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 5,
      "title": "Pfizer Inc. (PFE) Proposed Acquisition of Metsera, Inc. (NYSE:PFE) 2025-09-22",
      "source": {
        "name": "Seeking Alpha",
        "icon": "https://encrypted-tbn3.gstatic.com/faviconV2?url=https://seekingalpha.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://seekingalpha.com/article/4824901-pfizer-inc-pfe-proposed-acquisition-of-metsera-inc",
      "thumbnail": "https://static1.seekingalpha.com/uploads/sa_presentations/670/114670/slides/1.jpg?io=w640&ts=1758563265",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iJ0NnNTBWa2xXWlUxSFdteHdOekpNVFJEb0FoaUFCU2dLTWdNQkpBQQ",
      "date": "09/22/2025, 05:47 PM, +0000 UTC"
    }
  },
  {
    "headline": "With 67% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns",
    "summary": null,
    "source_url": "https://finance.yahoo.com/news/67-institutional-ownership-pfizer-inc-110011345.html",
    "published": "09/24/2025, 11:00 AM, +0000 UTC",
    "source_name": "Yahoo Finance",
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 6,
      "title": "With 67% institutional ownership, Pfizer Inc. (NYSE:PFE) is a favorite amongst the big guns",
      "source": {
        "name": "Yahoo Finance",
        "icon": "https://encrypted-tbn1.gstatic.com/faviconV2?url=https://finance.yahoo.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://finance.yahoo.com/news/67-institutional-ownership-pfizer-inc-110011345.html",
      "date": "09/24/2025, 11:00 AM, +0000 UTC"
    }
  },
  {
    "headline": "PFIZER INC : Receives a Buy rating from Jefferies",
    "summary": null,
    "source_url": "https://www.marketscreener.com/news/pfizer-inc-receives-a-buy-rating-from-jefferies-ce7d58dddc81f22d",
    "published": "09/24/2025, 06:29 AM, +0000 UTC",
    "source_name": "MarketScreener",
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 7,
      "title": "PFIZER INC : Receives a Buy rating from Jefferies",
      "source": {
        "name": "MarketScreener",
        "icon": "https://encrypted-tbn2.gstatic.com/faviconV2?url=https://www.marketscreener.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://www.marketscreener.com/news/pfizer-inc-receives-a-buy-rating-from-jefferies-ce7d58dddc81f22d",
      "thumbnail": "https://www.marketscreener.com/zbcache/charts/ObjectChart.aspx?Name=23365019&Type=Custom&Intraday=1&Width=392&Height=392&Cycle=DAY1&Duration=5&Render=Candle&ShowCopyright=2&ShowName=0&Locale=en&ShowVolume=1&Company=Skin:ZonebourseLight&externload=",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iK0NnNXdjVU5JWlRkWVRuZE5WbFl3VFJDSUF4aUlBeWdLTWdhQkFwQ0tOUWM",
      "date": "09/24/2025, 06:29 AM, +0000 UTC"
    }
  },
  {
    "headline": "How Pfizer Inc. (PFE) Affects Rotational Strategy Timing",
    "summary": null,
    "source_url": "https://news.stocktradersdaily.com/news_release/95/How_Pfizer_Inc._PFE_Affects_Rotational_Strategy_Timing_092425024202_1758696122.html",
    "published": "09/24/2025, 02:42 AM, +0000 UTC",
    "source_name": "news.stocktradersdaily.com",
    "fetched": "2025-09-24T14:43:06.373057",
    "provenance": {
      "position": 8,
      "title": "How Pfizer Inc. (PFE) Affects Rotational Strategy Timing",
      "source": {
        "name": "news.stocktradersdaily.com",
        "icon": "https://encrypted-tbn2.gstatic.com/faviconV2?url=https://news.stocktradersdaily.com&client=NEWS_360&size=96&type=FAVICON&fallback_opts=TYPE,SIZE,URL"
      },
      "link": "https://news.stocktradersdaily.com/news_release/95/How_Pfizer_Inc._PFE_Affects_Rotational_Strategy_Timing_092425024202_1758696122.html",
      "thumbnail": "https://news.stocktradersdaily.com/media/633332_PFE_graph.jpg",
      "thumbnail_small": "https://news.google.com/api/attachments/CC8iJ0NnNDRXa3h6UWtKck5teE5WMUpoVFJEZUFoaWdCaWdLTWdNUlFoUQ",
      "date": "09/24/2025, 02:42 AM, +0000 UTC"
    }
  }
]